hydralazine has been researched along with Compensatory Hyperinsulinemia in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamide, K | 1 |
| Rakugi, H | 1 |
| Higaki, J | 1 |
| Okamura, A | 1 |
| Nagai, M | 1 |
| Moriguchi, K | 1 |
| Ohishi, M | 1 |
| Satoh, N | 1 |
| Tuck, ML | 1 |
| Ogihara, T | 1 |
1 other study available for hydralazine and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood | 2002 |